These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 15996721)

  • 21. The impact of allogenic red cell transfusion and coated bypass circuit on the inflammatory response during cardiopulmonary bypass: a randomized study.
    Senay S; Toraman F; Gunaydin S; Kilercik M; Karabulut H; Alhan C
    Interact Cardiovasc Thorac Surg; 2009 Jan; 8(1):93-9. PubMed ID: 18801802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of fibrinolysis in the pericardial cavity during cardiopulmonary bypass.
    Tabuchi N; de Haan J; Boonstra PW; van Oeveren W
    J Thorac Cardiovasc Surg; 1993 Nov; 106(5):828-33. PubMed ID: 8231204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of aprotinin and tranexamic acid on thrombin generation and fibrinolytic response after cardiac surgery.
    Kuitunen A; Hiippala S; Vahtera E; Rasi V; Salmenperä M
    Acta Anaesthesiol Scand; 2005 Oct; 49(9):1272-9. PubMed ID: 16146463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy-induced activation of hemostasis: effect of a low molecular weight heparin (dalteparin sodium) on plasma markers of hemostatic activation.
    Weitz IC; Israel VK; Waisman JR; Presant CA; Rochanda L; Liebman HA
    Thromb Haemost; 2002 Aug; 88(2):213-20. PubMed ID: 12195692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is reduced systemic heparinization justified with heparin-bonded bypass circuits in cardiac surgery?--Experience with and without aprotinin.
    Kipfer B; Englberger L; Gygax E; Nydegger U; Carrel T
    Transfus Apher Sci; 2003 Aug; 29(1):17-24. PubMed ID: 12877888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of protein C and hemodynamic recovery after coronary artery bypass surgery.
    Raivio P; Fernández JA; Kuitunen A; Griffin JH; Lassila R; Petäjä J
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):44-51. PubMed ID: 17198779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of cardiac ischemia and reperfusion on markers of activated haemostasis and fibrinolysis during cardiopulmonary bypass: comparison of plasma levels in arterial and coronary venous blood.
    Kalweit G; Bach J; Huwer H; Winning J; Hellstern P
    Thromb Res; 2005; 116(1):33-9. PubMed ID: 15850606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Epsilon amino-caproic acid (EACA) and autologous blood as blood conservation strategies in patients undergoing cardiac surgery.
    Sharma V; Talwar S; Choudhary SK; Lakshmy R; Kale S; Kumar AS
    Heart Lung Circ; 2006 Aug; 15(4):261-5. PubMed ID: 16698318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Joiner-Maier D; Santoro SA; Spitznagel E; Weitz JI; Goodnough LT
    Thromb Haemost; 1996 Dec; 76(6):902-8. PubMed ID: 8972009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemostasis at low heparin dosage during cardiopulmonary bypass with heparin-coated circuits in pigs.
    Bagge L; Borowiec JW; Thelin S; Hultman J
    Scand Cardiovasc J; 1997; 31(5):275-81. PubMed ID: 9406294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
    Kutay V; Noyan T; Ozcan S; Melek Y; Ekim H; Yakut C
    J Card Surg; 2006; 21(6):572-7. PubMed ID: 17073955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of nafamostat mesilate on platelets and coagulofibrinolysis during cardiopulmonary bypass surgery.
    Tanaka K; Kondo C; Takagi K; Sato T; Yada I; Yuasa H; Kusagawa M
    ASAIO J; 1993; 39(3):M545-9. PubMed ID: 8268595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers.
    Slaughter TF; LeBleu TH; Douglas JM; Leslie JB; Parker JK; Greenberg CS
    Anesthesiology; 1994 Mar; 80(3):520-6. PubMed ID: 8141448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haemostasis at low heparin dosage during cardiopulmonary bypass with heparin-coated circuits in pigs.
    Bagge L; Borowiec JW; Thelin S; Hultman J
    Scand Cardiovasc J; 1997; 31(6):275-81. PubMed ID: 9498931
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early activation of hemostasis during cardiopulmonary bypass: evidence for thrombin mediated hyperfibrinolysis.
    Teufelsbauer H; Proidl S; Havel M; Vukovich T
    Thromb Haemost; 1992 Sep; 68(3):250-2. PubMed ID: 1440486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antithrombin deficiency increases thrombin activity after prolonged cardiopulmonary bypass.
    Sniecinski R; Szlam F; Chen EP; Bader SO; Levy JH; Tanaka KA
    Anesth Analg; 2008 Mar; 106(3):713-8, table of contents. PubMed ID: 18292407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Heparin concentration and hemostatic alterations with low systemic heparinization during CPB using heparin-coated circuits].
    Yoshie M; Hirose Y; Gamo M; Matsuo K
    Masui; 2001 Feb; 50(2):179-83. PubMed ID: 11244775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conjunctive administration of intravenous heparin attenuates cross-linked fibrin degradation in patients treated with streptokinase.
    Galvani M; Abendschein DR; Ferrini D; Ottani F; Rusticali F; Eisenberg PR
    Thromb Haemost; 1996 Sep; 76(3):339-43. PubMed ID: 8883267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.